Cargando…

SWiss Atorvastatin and Interferon Beta-1b Trial In Multiple Sclerosis (SWABIMS) - rationale, design and methodology

BACKGROUND: Statins have anti-inflammatory and immunomodulatory properties in addition to their lipid-lowering effects. Currently, the effects of statins on multiple sclerosis are still controversial. Therefore, randomized clinical trials are needed to provide better evidence on the therapeutic pote...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kamm, Christian P, Mattle, Heinrich P
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Study protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2801665/ https://www.ncbi.nlm.nih.gov/pubmed/20003436 http://dx.doi.org/10.1186/1745-6215-10-115

Ejemplares similares

Atorvastatin Added to Interferon Beta for Relapsing Multiple Sclerosis: 12-Month Treatment Extension of the Randomized Multicenter SWABIMS Trial
por: Kamm, Christian P., et al.
Publicado: (2014)

Atorvastatin added to interferon beta for relapsing multiple sclerosis: a randomized controlled trial
por: Kamm, Christian Philipp, et al.
Publicado: (2012)

Variables Related to Working Capability among Swiss Patients with Multiple Sclerosis—A Cohort Study
por: Findling, Oliver, et al.
Publicado: (2015)

Nurse forecasting in Europe (RN4CAST): Rationale, design and methodology
por: Sermeus, Walter, et al.
Publicado: (2011)

The German Multiple Sclerosis and Pregnancy Registry: rationale, objective, design, and first results
por: Thiel, Sandra, et al.
Publicado: (2021)

Sustaining remission of psychotic depression: rationale, design and methodology of STOP-PD ΙΙ
por: Flint, Alastair J, et al.
Publicado: (2013)

Rationale, design, and methodology for the optimizing outcomes in women with gestational diabetes mellitus and their infants study
por: Berry, Diane C, et al.
Publicado: (2013)

Randomized clinical trial comparing percutaneous closure of patent foramen ovale (PFO) using the Amplatzer PFO Occluder with medical treatment in patients with cryptogenic embolism (PC-Trial): rationale and design
por: Khattab, Ahmed A, et al.
Publicado: (2011)

Rationale, design, and methodology for the healthy mothers-healthy children study: a randomized controlled trial
por: Berry, Diane C., et al.
Publicado: (2019)

The Nakuru eye disease cohort study: methodology & rationale
por: Bastawrous, Andrew, et al.
Publicado: (2014)

The Canadian prospective cohort study to understand progression in multiple sclerosis (CanProCo): rationale, aims, and study design
por: Oh, Jiwon, et al.
Publicado: (2021)

Response to Interferon-Beta Treatment in Afro-Caribbeans with Multiple Sclerosis
por: Jeannin, S., et al.
Publicado: (2011)

Rationale, design, methodology and sample characteristics for the family partners for health study: a cluster randomized controlled study
por: Berry, Diane C, et al.
Publicado: (2012)

The Nigerian national blindness and visual impairment survey: Rationale, objectives and detailed methodology
por: Dineen, Brendan, et al.
Publicado: (2008)

Rationale, design, and methodology of a trial evaluating three models of care for HCV treatment among injection drug users on opioid agonist therapy
por: Akiyama, Matthew J., et al.
Publicado: (2018)

How is and how should healthcare for people with multiple sclerosis in Germany be designed?–The rationale and protocol for the mixed-methods study Multiple Sclerosis–Patient-Oriented Care in Lower Saxony (MS-PoV)
por: Krüger, Kathrin, et al.
Publicado: (2021)

Rationale, design and methodology for Intraventricular Pressure Gradients Study: a novel approach for ventricular filling assessment in normal and falling hearts
por: Guerra, Miguel, et al.
Publicado: (2011)

Rationale, design, methodology and sample characteristics for the Vietnam pre-conceptual micronutrient supplementation trial (PRECONCEPT): a randomized controlled study
por: Nguyen, Phuong H, et al.
Publicado: (2012)

Strength Training for Arthritis Trial (START): design and rationale
por: Messier, Stephen P, et al.
Publicado: (2013)

Rationale, design and methodology of a double-blind, randomized, placebo-controlled study of escitalopram in prevention of Depression in Acute Coronary Syndrome (DECARD)
por: Hansen, Baiba Hedegaard, et al.
Publicado: (2009)

Pacific Islands Cohort on Cardiometabolic Health Study: rationale and design
por: Guerrero, Rachael T. Leon, et al.
Publicado: (2022)

Rationales, design and recruitment for the Elfe longitudinal study
por: Vandentorren, Stéphanie, et al.
Publicado: (2009)

Rationales, design and recruitment of the Taizhou Longitudinal Study
por: Wang, Xiaofeng, et al.
Publicado: (2009)

Rationale for a home dialysis virtual ward: design and implementation
por: Schachter, Michael E, et al.
Publicado: (2014)

The Intensive Diet and Exercise for Arthritis (IDEA) trial: design and rationale
por: Messier, Stephen P, et al.
Publicado: (2009)

Investigating the association of traditional and non-traditional tobacco product use with subclinical and clinical cardiovascular disease: The Cross-Cohort Collaboration-Tobacco working group rationale, design, and methodology
por: Tasdighi, Erfan, et al.
Publicado: (2023)

POPE study: rationale and methodology of a study to phenotype patients with COPD in Central and Eastern Europe
por: Zbozinkova, Zuzana, et al.
Publicado: (2016)

Shanghai cognitive intervention of mild cognitive impairment for delaying progress with longitudinal evaluation-a prospective, randomized controlled study (SIMPLE): rationale, design, and methodology
por: Lin, Yiqi, et al.
Publicado: (2018)

Managing the link and strengthening transition from child to adult mental health Care in Europe (MILESTONE): background, rationale and methodology
por: Tuomainen, H., et al.
Publicado: (2018)

Rationale and design of the Chinese Atrial Fibrillation Registry Study
por: Du, Xin, et al.
Publicado: (2016)

LucKi Birth Cohort Study: rationale and design
por: de Korte-de Boer, Dianne, et al.
Publicado: (2015)

Financial incentives for hypertension control: rationale and study design
por: Zheng, Liqiang, et al.
Publicado: (2020)

The national COPD screening programme in China: rationale and design
por: Lei, Jieping, et al.
Publicado: (2023)

Effect of cool vs. warm dialysate on toxin removal: rationale and study design
por: Maheshwari, Vaibhav, et al.
Publicado: (2015)

Breast ductal lavage for biomarker assessment in high risk women: rationale, design and methodology of a randomized phase II clinical trial with nimesulide, simvastatin and placebo
por: Lazzeroni, Matteo, et al.
Publicado: (2012)

Latin American Study of Nutrition and Health (ELANS): rationale and study design
por: Fisberg, M., et al.
Publicado: (2016)

Rationale and design of the brain magnetic resonance imaging protocol for FutureMS: a longitudinal multi-centre study of newly diagnosed patients with relapsing-remitting multiple sclerosis in Scotland
por: Meijboom, Rozanna, et al.
Publicado: (2022)

The sequential natalizumab – alemtuzumab therapy in patients with relapsing forms of multiple sclerosis (SUPPRESS) trial – Part I: Rationale and objectives
por: Hussain, Rehana Z, et al.
Publicado: (2022)

The Swiss Multiple Sclerosis Registry (SMSR): study protocol of a participatory, nationwide registry to promote epidemiological and patient-centered MS research
por: Steinemann, Nina, et al.
Publicado: (2018)

A randomized controlled trial to evaluate an educational strategy involving community health volunteers in improving self-care in patients with chronic heart failure: Rationale, design and methodology
por: Siabani, Soraya, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_1pbo3oflfjtpvokc9h6s7muj8a